- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04825821
Cesarean Scar Defects After Uterine Closure by Double-layer Barbed or Smooth Suture
December 27, 2022 updated by: Fabio Barra, Ospedale Policlinico San Martino
A Prospective Pilot Study Comparing Incidence and Characteristics of Cesarean Scar Defects After Uterine Closure by Double-layer Barbed or Smooth Suture
Late sequelae of a cesarean section related to a uterine scar defects include gynecological symptoms and obstetric complications.
The aim of this study was to evaluate the incidence and characteristics of cesarean scar defects after uterine closure by double-layer barbed suture.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
247
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Genoa, Italy, 16132
- IRCCS Ospedale Policlinico San Martino
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patients who underwent elective cesarean section at ≥37 weeks of gestation
Description
Inclusion Criteria:
- Patients who underwent elective cesarean section at ≥ 37 weeks of gestation
Exclusion Criteria:
- Patients who underwent concomitant surgical procedures during the cesarean section (i.e., tubal sterilization);
- Patients who underwent a previous abdominal surgery (with exception of appendectomy) including a cesarean section or other laparotomic/laparoscopic uterine surgical procedure (i.e., myomectomy);
- Patients who had a previous diagnosis of Mullerian uterine anomalies elective cesarean for the second time or after uterine surgery;
- Patients who had evidence of PAS disorders or placenta previa.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Low transverse hysterotomy closed by double-layer unidirectional barbed suture
Patients who had undergone cesarean section during which the low transverse hysterotomy was closed by double-layer unidirectional barbed suture
|
Routinely assessment by objective examination and transvaginal ultrasonographic scan 6, 12, and 24 months after the surgical procedures
|
Low transverse hysterotomy closed by conventional double-layer smooth suture
Patients who had undergone cesarean section during which the low transverse hysterotomy was closed by conventional double-layer smooth suture
|
Routinely assessment by objective examination and transvaginal ultrasonographic scan 6, 12, and 24 months after the surgical procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of uterine scar defects
Time Frame: 6 months after the cesarean section
|
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
|
6 months after the cesarean section
|
Number of uterine scar defects
Time Frame: 12 months after the cesarean section
|
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
|
12 months after the cesarean section
|
Number of uterine scar defects
Time Frame: 24 months after the cesarean section
|
Number of simple and complex uterine scar defects is evaluated by transvaginal ultrasound
|
24 months after the cesarean section
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 6 months after the cesarean section
|
RMT, depth, width, and length are evaluated by transvaginal ultrasound
|
6 months after the cesarean section
|
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 12 months after the cesarean section
|
RMT, depth, width, and length are evaluated by transvaginal ultrasound
|
12 months after the cesarean section
|
Residual myometrium thickness (RMT), depth, width and length of uterine scar defects
Time Frame: 24 months after the cesarean section
|
RMT, depth, width, and length are evaluated by transvaginal ultrasound
|
24 months after the cesarean section
|
Number of patients with postmenstrual spotting
Time Frame: 6 months after the cesarean section
|
Number of patients with postmenstrual spotting is evaluated by medical interview
|
6 months after the cesarean section
|
Number of patients with postmenstrual spotting
Time Frame: 12 months after the cesarean section
|
Number of patients with postmenstrual spotting is evaluated by medical interview
|
12 months after the cesarean section
|
Number of patients with postmenstrual spotting
Time Frame: 24 months after the cesarean section
|
Number of patients with postmenstrual spotting is evaluated by medical interview
|
24 months after the cesarean section
|
Number of patients with dysmenorrhea
Time Frame: 6 months after the cesarean section
|
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
|
6 months after the cesarean section
|
Number of patients with dysmenorrhea
Time Frame: 12 months after the cesarean section
|
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
|
12 months after the cesarean section
|
Number of patients with dysmenorrhea
Time Frame: 24 months after the cesarean section
|
Number of patients with dysmenorrhea is evaluated by medical interview with VAS (visual analogue scale)
|
24 months after the cesarean section
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Fabio Barra, MD, IRCCS Ospedale Policlinico San Martino
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Agarwal S, D'Souza R, Ryu M, Maxwell C. Barbed vs conventional suture at cesarean delivery: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2021 Jun;100(6):1010-1018. doi: 10.1111/aogs.14080. Epub 2021 Feb 5.
- Alessandri F, Evangelisti G, Centurioni MG, Gustavino C, Ferrero S, Barra F. Fishbone double-layer barbed suture in cesarean section: a help in preventing long-term obstetric sequelae? Arch Gynecol Obstet. 2021 Sep;304(3):573-576. doi: 10.1007/s00404-021-06121-8.
- Jordans IPM, de Leeuw RA, Stegwee SI, Amso NN, Barri-Soldevila PN, van den Bosch T, Bourne T, Brolmann HAM, Donnez O, Dueholm M, Hehenkamp WJK, Jastrow N, Jurkovic D, Mashiach R, Naji O, Streuli I, Timmerman D, van der Voet LF, Huirne JAF. Sonographic examination of uterine niche in non-pregnant women: a modified Delphi procedure. Ultrasound Obstet Gynecol. 2019 Jan;53(1):107-115. doi: 10.1002/uog.19049.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2019
Primary Completion (Actual)
July 30, 2022
Study Completion (Actual)
September 30, 2022
Study Registration Dates
First Submitted
March 27, 2021
First Submitted That Met QC Criteria
March 30, 2021
First Posted (Actual)
April 1, 2021
Study Record Updates
Last Update Posted (Actual)
December 30, 2022
Last Update Submitted That Met QC Criteria
December 27, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- BARB-CSCAR
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section Complications
-
Assiut UniversityNot yet recruitingCesarean Section Complications | Cesarean Section Niche
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Atatürk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
University of CalgaryNot yet recruitingCesarean Section ComplicationsCanada
-
Peking University People's HospitalNot yet recruiting
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt
-
Gaziosmanpasa Research and Education HospitalUnknownCesarean Section ComplicationsTurkey
-
Ain Shams UniversityUnknownCesarean Section ComplicationsEgypt
-
Mohamed Abdelrady MohamedCompletedCesarean Section ComplicationsEgypt
-
McGill University Health Centre/Research Institute...Thammasat UniversityUnknownCesarean Section ComplicationsCanada
Clinical Trials on Clinical and ultrasonographic assessment
-
Nova Scotia Health AuthorityCompleted
-
Universiteit AntwerpenUniversitaire Ziekenhuizen KU Leuven; Jagiellonian University; Catholic University... and other collaboratorsRecruiting
-
Hacettepe UniversityCompletedOsteoarthritis, KneeTurkey
-
Marmara UniversityCompletedPostmastectomy Lymphedema SyndromeTurkey
-
Florida International UniversityNational Institute of Mental Health (NIMH); University of MiamiCompletedDisruptive BehaviorUnited States
-
Thomas Jefferson UniversityCompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
Fondazione Don Carlo Gnocchi OnlusCompletedChronic Low-back PainItaly
-
Czech Technical University in PragueMayo Clinic; University Hospital, Montpellier; McGill University Health Centre... and other collaboratorsUnknownParkinson Disease | REM Sleep Behavior DisorderUnited States, Canada, Austria, Czechia, France, Germany, Italy
-
Halic UniversityCompletedTemporomandibular Joint Dysfunction SyndromeTurkey